Recombinant activated factor VII in controlling life-threatening bleeding in Dengue shock syndrome.

被引：0
|
作者：
Chuansumrit, A
Tangararatchakit, K
Lektrakul, Y
Pongthanapisith, V
Nimjaroenniyom, N
Thanarattankorn, P
Wongchanchaitert, M
机构：
[1] Ramathibodi Hosp, Bangkok, Thailand
[2] Supprasithprasong Hosp, Ubon Rajchathani, Thailand
[3] Khon Kaen Hosp, Khon Kaen, Thailand
[4] Chiang Mai Univ, Chiang Mai 50000, Thailand
[5] Prince Songkla Univ, Hat Yai, Thailand
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3799
引用
收藏
页码：82B / 82B
页数：1
相关论文
共 50 条
  • [31] Recombinant Activated Factor VII Usage in Life Threatening Hemorrhage: A Pediatric Experience
    Bhat, Sunil
    Yadav, Satya Prakash
    Anjan, Madasu
    Dinand, Veronique
    Sachdeva, Anupam
    INDIAN JOURNAL OF PEDIATRICS, 2011, 78 (08): : 961 - 968
  • [32] Recombinant Activated Factor VII Usage in Life Threatening Hemorrhage: A Pediatric Experience
    Sunil Bhat
    Satya Prakash Yadav
    Madasu Anjan
    Veronique Dinand
    Anupam Sachdeva
    The Indian Journal of Pediatrics, 2011, 78 : 961 - 968
  • [33] Succesful management of life-threatening hemorrhage in a patient with osteogenesis imperfecta by low-dose activated recombinant factor VII
    Annick Becotte
    P. Moliner
    G. Devroede
    H. Knecht
    Canadian Journal of Anaesthesia, 2008, 55 (Suppl 1) : 4718291 - 4718292
  • [34] Recombinant activated factor VII for perioperative bleeding
    Lopez B, Rodrigo
    Aeschlimann D, Nicolas
    Carvajal F, Claudia
    Lema F, Guillermo
    REVISTA MEDICA DE CHILE, 2009, 137 (06) : 837 - 843
  • [35] Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis
    Borrás-Blasco, J
    Conesa-García, V
    Navarro-Ruiz, A
    Palacios-Ortega, F
    Gómez, A
    PANCREAS, 2005, 31 (03) : 292 - 294
  • [36] Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices
    Antoine G. Schneider
    Marie-Hélène Perez
    Piergiorgio Tozzi
    Pierre Voirol
    Patrick Schoettker
    Anne Angelillo-Scherrer
    Jacques Cotting
    Ludwig Von Segesser
    Philippe Eggimann
    Intensive Care Medicine, 2010, 36 : 1620 - 1621
  • [37] Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices
    Schneider, Antoine G.
    Perez, Marie-Helene
    Tozzi, Piergiorgio
    Voirol, Pierre
    Schoettker, Patrick
    Angelillo-Scherrer, Anne
    Cotting, Jacques
    Von Segesser, Ludwig
    Eggimann, Philippe
    INTENSIVE CARE MEDICINE, 2010, 36 (09) : 1620 - 1621
  • [38] On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation
    Gerotziafas, GT
    Zervas, K
    Arzoglou, P
    Karavaggeli, E
    Parashou, S
    Van Dreden, P
    Christakis, J
    Samama, MM
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 705 - 708
  • [39] ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII USAGE FOR BLEEDING CONTROL IN CASES OF HEMORRHAGIC SHOCK
    Lee, B. Y.
    Park, J. H.
    Huh, J. W.
    Lim, C. -M.
    Koh, Y.
    Hong, S. -B.
    INTENSIVE CARE MEDICINE, 2011, 37 : S49 - S49
  • [40] Use of Recombinant Factor VII a (NovoSeven) in Patients with Ongoing Life Threatening Bleeding Treated with Fondaparinux
    Schiele, Francois
    Luporsi, Paul
    Meneveau, Nicolas
    Racadot, Evelyne
    Descotes-Genon, Vincent
    Chopard, Romain
    Seronde, Marie-France
    Janin, Sebastien
    CIRCULATION, 2010, 122 (21)
12345